Although the DAS-28 score was decreased and indicated an improvement in the patient’s clinical condition, confirming the beneficial effects of DMARDs treatment, the increase in oxidative stress parameters linked to ER-α expression suggests a greater tendency of RBCs of RA patients in the pro-oxidant state associated with the expression of survival molecules, such as survivin. The gene discussed is BIRC5; the disease is rheumatoid arthritis.